From Name:
From Email:
To Name:
To Email:

Optional Message:


Study finds only half of patients receive recommended initial dose of Butrans

from Pharmacy Times

Butrans Transdermal System is "a partial opioid-agonist product indicated for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time." According to the Full Prescribing Information, initial Butrans dosing should be based on the individual patient's prior analgesic treatment experience and should be titrated as needed "to provide adequate analgesia and minimize adverse reactions." more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063